Screening for Cognitive Decline in Psychotic Disorders in Midlife: Examining Scoring the Clinical Dementia Rating Using Longitudinal Data
Future work should include observed decline in cognition and functioning to examine cognitive impairment in psychosis. Changes in CDR score may be important when managing treatment.
Authors
- Evelyn J. Bromet (ORCID: https://orcid.org/0000-0002-2648-5793)
- Katherine Jonas (ORCID: https://orcid.org/0000-0002-1910-223X)
- Sean Clouston (ORCID: https://orcid.org/0000-0002-6124-0329)
- Philip D. Harvey (ORCID: https://orcid.org/0000-0002-9501-9366)
- Roman Kotov (ORCID: https://orcid.org/0000-0001-9569-8381)
- Wen Lian (ORCID: https://orcid.org/0009-0009-5364-7151)
- Yuan Yang (ORCID: https://orcid.org/0000-0003-2138-5811)
- Constantine G. Lyketsos
Institutions
- Johns Hopkins University (US)
- University of Miami (US)
- Johns Hopkins Bayview Medical Center (US)
- Stony Brook Medicine (US)
- Bruce W. Carter VA Medical Center (US)
- Stony Brook University (US)
Publication Details
- Journal
- Schizophrenia Bulletin
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1093/schbul/sbaf080
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00